CYP46A1 and Alzheimer disease: Thus, soluble Aβ-induced ATAD3A oligomerization via the ATAD3A-CYP46A1-APP signaling axis may exacerbate Aβ deposition and contribute to the AD pathology observed later in both animals and patients.